Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of CS-3150 to Evaluate Efficacy and Safety in Patients With Primary Aldosteronism

NCT02885662 is registered in ClinicalTrials.gov with Daiichi Sankyo Co., Ltd. as lead sponsor.

NCT NCT02885662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02885662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of CS-3150 to Evaluate Efficacy and Safety in Patients With Primary Aldosteronism
Lead sponsor
Daiichi Sankyo Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2016
Completion date
July 20, 2017
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary aldosteronism